Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Wasdell Sponsor Swindon & Wiltshire, Health & Social Care Awards
March 24, 2021 / by Wasdell Group /
Read more
Wasdell Group strengthens PPFL business with ISO 13485 for medical devices
December 2, 2020 / by Wasdell Group /
The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has today announced that its Dundalk, Ireland facility has been certified to comply with the ISO 13485 standard for medical device manufacturing. The ISO 13485 is an internationally recognised certification, ensuring that the company’s quality management system complies to customer […]
Read more
Direct-to-patient services in practice: COVID 19 case studies
September 7, 2020 / by Wasdell Group /
The Covid 19 pandemic has placed additional emphasis on the healthcare industry shift towards more patient-centric approaches, particularly with clinical trials. Increasingly, services such as Direct-to-Patient (DtP) and Direct-from-Patient (DfP) shipment approaches are now being viewed as critical. Delivering Investigational Medicinal Product (IMP) to patients participating in clinical trials requires the establishment of a framework […]
Read more
The rise of direct-to-patient services
September 7, 2020 / by Wasdell Group /
The COVID-19 pandemic has significantly disrupted clinical trials, yet the industry is adapting and finding opportunities and new ways to serve patients. Logistical challenges, including the inability of patients to attend clinics has placed added emphasis on Direct-to-Patient (DtP) services. So, in the current climate why should DtP clinical trial material shipments be integrated into […]
Read more
Wasdell Group granted IMP licence for European headquarters
May 28, 2020 / by Wasdell Group /
Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has been granted an Investigational Medicinal Product (IMP) licence by the Health Products Regulatory Authority (HPRA) at its Dundalk, Ireland facility. This licence enables Wasdell to expand the facility’s services to include clinical importation and distribution. Wasdell’s facilities in Swindon and Newcastle, UK already have an IMP […]
Read more
Wasdell makes multi-million-pound investment in new packaging equipment
May 6, 2020 / by Wasdell Group /
Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has announced a multi-million-pound investment in new packaging equipment across its sites in the UK and Ireland. The company, which specialises in end-to-end supply chain services, made the decision to invest in line with increasing demand for its manufacturing & packaging capabilities from its growing pharma and […]
Read more
Wasdell acquires specialist packaging supplier
April 23, 2020 / by Wasdell Group /
The Wasdell Group, a leading outsourcing partner to the pharmaceutical industry, has announced its acquisition of Planned Packaging Limited & Planned Packaging Films Limited (PPF), a specialist packaging supplier to the medical device and pharmaceutical sectors. The acquisition will strengthen and expand Wasdell’s capability to be a fully integrated supplier to its growing client base […]
Read more
COVID-19: A statement from our CEO
March 20, 2020 / by Wasdell Group /
The Wasdell Group want to update you on the current actions being taken to navigate the spread of COVID-19. Above all, we want to reassure our employees, customers and community that we are taking proactive action to maintain safety and minimise impact on our supply chains throughout this difficult time. Our operations continue to run […]
Read more
Operations commence at Wasdell Group’s EU headquarters
July 5, 2019 / by Wasdell Group /
The Wasdell Group (Wasdell), a leading outsourcing partner for the pharmaceutical industry, has today announced its new state-of-the-art facility in Dundalk, Ireland has received its Manufacturer’s / Importation Authorisation licence (MIA) from the Health Products Regulatory Authority (HPRA). The new EU headquarters, which are a result of a significant investment in a greenfield site at […]
Read more
Wasdell Group extends business into the US
March 14, 2019 / by Wasdell Group /
We are delighted to announce that this year the Wasdell Group has recently established a presence within the United States, with a new US entity secured in Pennsylvania. The US presence comes as part of Wasdell’s latest step in extending our global reach to support our business activity and establish a local presence for our […]
Read more